08/10/2018 | Kyowa Hakko Bio Co., Ltd. | Center for Drug Evaluation and Research | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated | Not Issued * |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, August 21, 2018
07/31/2018 | Hangzhou Karic Commodities Co., Ltd. | Center for Drug Evaluation and Research | CGMP/Finished Pharmaceuticals/Adulterated | Not Issued * |
Monday, August 20, 2018
Question of the Day August 20, 2018: "Of the 547 pharmacies with questionable billing for compounded topical drugs, 154 were located in the New York, Houston, Detroit, and Los Angeles metropolitan areas. " What is the reason for this? What is the common thread, if any, among these pharmacies and/or cities with the highest questionable compounding billing?
Subscribe to:
Posts (Atom)